Critics continue to pile on as CRISPR researcher describes informed consent, review process

Jiankui He outlined the peer review and informed consent process used in the first-ever human CRISPR germline gene editing trial at the International Summit on Human Genome Editing on Wednesday. However, critics decried the process as irresponsible and opaque, while a consensus statement from the research community on next steps

Read the full 505 word article

How to gain access

Continue reading with a
two-week free trial.